Pros and cons for fluorescent in situ hybridization, karyotyping and next generation sequencing for diagnosis and follow-up of multiple myeloma
By: E Ikbal Atli, H Gurkan, H Onur Kirkizlar, E Atli, S Demir, S Yalcintepe, R Kalkan and AM Demir
Authors
E Ikbal Atli
Department of Medical Genetics, Faculty of Medicine, Edirne, Trakya University, Edirne, Turkey
H Gurkan
Department of Medical Genetics, Faculty of Medicine, Edirne, Trakya University, Edirne, Turkey
H Onur Kirkizlar
Department of Hematology, Faculty of Medicine, Trakya University, Edirne, Turkey
E Atli
Department of Medical Genetics, Faculty of Medicine, Edirne, Trakya University, Edirne, Turkey
S Demir
Department of Medical Genetics, Faculty of Medicine, Edirne, Trakya University, Edirne, Turkey
S Yalcintepe
Department of Medical Genetics, Faculty of Medicine, Edirne, Trakya University, Edirne, Turkey
R Kalkan
Department of Medical Genetics, Faculty of Medicine, Near East University, North Nicosia, Northern Cyprus
AM Demir
Department of Hematology, Faculty of Medicine, Trakya University, Edirne, Turkey
DOI: https://doi.org/10.2478/bjmg-2020-0020 | Journal eISSN: 2199-5761
Language: English
Page range: 59 - 64
Published on: Mar 23, 2021
Published by: Macedonian Academy of Sciences and Arts
In partnership with: Paradigm Publishing Services
Publication frequency: 2 issues per year
Keywords:
Related subjects:
© 2021 E Ikbal Atli, H Gurkan, H Onur Kirkizlar, E Atli, S Demir, S Yalcintepe, R Kalkan, AM Demir, published by Macedonian Academy of Sciences and Arts
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.